NCT05802212View on ClinicalTrials.gov

Effect of Metformin on Patients With Polycystic Ovary Syndrome

NACompletedINTERVENTIONAL
Enrollment

300

Participants

Timeline

Start Date

June 1, 2020

Primary Completion Date

June 1, 2022

Study Completion Date

May 1, 2023

Conditions
PCOS (Polycystic Ovary Syndrome) of Bilateral Ovaries
Interventions
DRUG

Metformin intervention for 12 weeks

PCOS patients were treated with metformin orally for 12 weeks, and various indicators related to fertility were observed.

Trial Locations (1)

Unknown

Peking University Third Hospital, Beijing

All Listed Sponsors
lead

Peking University Third Hospital

OTHER

NCT05802212 - Effect of Metformin on Patients With Polycystic Ovary Syndrome | Biotech Hunter | Biotech Hunter